This phase II study demonstrated the efficacy of osimertinib 80 mg daily in patients with EGFR mutant NSCLC with leptomeningeal disease. The study designed included BICR using the RANO-LM assessment ...

With the Stanley Cup Playoffs moving along, the NHL is continuing the process of announcing the finalists for each of its major awards for the 2024-25 season. During the 2025 NHL Draft Lottery ...